TG Therapeutics to Participate in the B. Riley Securities Fall 2021 Growth Biotech Best Ideas Virtual SeriesGlobeNewsWire • 11/09/21
TG Therapeutics, Inc. (TGTX) CEO Mike Weiss on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/05/21
TG Therapeutics Highlights Data Selected for Presentation at the 63rd American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 11/04/21
TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/04/21
TG Therapeutics (TGTX) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 11/01/21
TG Therapeutics to Host Conference Call on Third Quarter 2021 Financial Results and Business UpdateGlobeNewsWire • 11/01/21
TG Therapeutics Announces Data for Ublituximab in Multiple Sclerosis Presented at the 37th Congress of the European Committee for Treatment and Research in Multiple SclerosisGlobeNewsWire • 10/14/21
TG Therapeutics Submits Biologics License Application to the U.S. Food and Drug Administration for Ublituximab as a Treatment for Patients with Relapsing Forms of Multiple SclerosisGlobeNewsWire • 09/30/21
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at 37th Congress of the European Committee for Treatment and Research in Multiple SclerosisGlobeNewsWire • 09/29/21
TG Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare ConferenceGlobeNewsWire • 09/23/21
TG Therapeutics Announces Combination Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)GlobeNewsWire • 09/20/21
TG Therapeutics Recaps Schedule of Upcoming Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)GlobeNewsWire • 09/13/21
TG Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/09/21
TG Therapeutics Announces Data Presentations at the Upcoming XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)GlobeNewsWire • 08/30/21
Do Options Traders Know Something About TG Therapeutics (TGTX) Stock We Don't?Zacks Investment Research • 08/16/21
TG Therapeutics, Inc. (TGTX) CEO Mike Weiss on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/02/21
TG Therapeutics Stock Plunged As H.C. Wainwright Cuts Target Price After Disappointing Q2Benzinga • 08/02/21